<code id='E5DDB13999'></code><style id='E5DDB13999'></style>
    • <acronym id='E5DDB13999'></acronym>
      <center id='E5DDB13999'><center id='E5DDB13999'><tfoot id='E5DDB13999'></tfoot></center><abbr id='E5DDB13999'><dir id='E5DDB13999'><tfoot id='E5DDB13999'></tfoot><noframes id='E5DDB13999'>

    • <optgroup id='E5DDB13999'><strike id='E5DDB13999'><sup id='E5DDB13999'></sup></strike><code id='E5DDB13999'></code></optgroup>
        1. <b id='E5DDB13999'><label id='E5DDB13999'><select id='E5DDB13999'><dt id='E5DDB13999'><span id='E5DDB13999'></span></dt></select></label></b><u id='E5DDB13999'></u>
          <i id='E5DDB13999'><strike id='E5DDB13999'><tt id='E5DDB13999'><pre id='E5DDB13999'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:leisure time    Page View:1147
          Two business miniatures talk to each other on coin stacks that are sandwiched by a syringe and a stethoscope — coverage from STAT
          Adobe

          For all the flak they get, the country’s four biggest pharmacy benefit managers reported a surprisingly tame average profit margin in the first three quarters of 2023: 4.5%, less than a third of their drugmaker peers.

          But don’t take their numbers as gospel, experts warned.

          advertisement

          “It’s really easy to move money around inside the books of a vertically integrated organization,” said Karen Van Nuys, a senior fellow at the USC Schaeffer Center for Health Policy and Economics. “If one segment of your vertically integrated organization is not publishing any financial data, it’s a good place to hide stuff.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more
          STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list
          STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

          AdobeThisarticleisadaptedfromthe2023editionofSTAT’sannualreport,“Rankingbiotech’stopventurecapitalfi

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

          AdobeThisarticleisadaptedfromthe2023editionofSTAT’sannualreport,“Rankingbiotech’stopventurecapitalfi